# Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

> **NCT00515151** · PHASE4 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 400 (actual)

## Conditions studied

- Catheterization, Central Venous
- Catheter-Associated Infections
- Bacterial Infections
- Bacteremia

## Interventions

- **DRUG:** 0.1% Octenidine with 30% 1-propanol and 45% 2-propanol
- **DRUG:** 74% Ethanol with 10% 2-propanol

## Key facts

- **NCT ID:** NCT00515151
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2007-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515151, "Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00515151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*